Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 21 hours ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 10 hours agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 9 hours agoOn May 10, 2024, Novavax Inc (NVAX, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The company, a prominent ...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 21 hours agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 9 hours agoCash and Cash Equivalents: Ended the quarter with $480.59 million, down from $568.51 million at the end of the previous quarter. On May 10, 2024, Novavax Inc (NASDAQ:NVAX) ...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi
Proactive Investors· 15 hours agoNovavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 18 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 18 hours agoNovavax NVAX shares surged 45% in Friday’s pre-market trading session having lost 50% of their value...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 11 hours agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 17 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...